With more than 50 proteins, the MicroVue™ Complement mediates a set of activities including the initiation of inflammation, disruption of cell membranes, clearance of immune complexes, regulation of the immune response and it also plays a role in several autoimmune diseases including rheumatoid arthritis, SLE, and acute glomerulonephritis.
The group of MicroVue™ Bone makes available a variety of enzyme immunoassays or biochemical markers of bone turnover that may be useful as independent predictors of fracture risk and rate of bone loss.